2 Million Brits Are Self Medicating With Cannabis, The Market Soars 10% Monthly - Will National Health Service Prescriptions Catch Up?
Portfolio Pulse from Nicolás Jose Rodriguez
The UK's medical cannabis market is growing rapidly, with a 10% monthly increase, driven by private sector involvement and increasing acceptance. However, NHS prescriptions remain limited, leading to a reliance on illicit channels. Curaleaf is expanding in the UK, offering pharmaceutical-grade cannabis at competitive prices to counter the illegal trade.
August 30, 2024 | 2:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Curaleaf is expanding its presence in the UK cannabis market, offering products like vapes and gummies at competitive prices to counter the illicit trade. This strategic move could enhance its market position and drive revenue growth.
Curaleaf's strategic expansion in the UK, offering competitively priced cannabis products, positions it well to capture market share from the illicit trade. This could lead to increased revenues and a stronger market presence, positively impacting its stock price.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80